Italy's economic recovery in 2006 depends on the growth of exports "to which the pharmaceutical sector has contributed considerably". The president of Farmindustria Sergio Dompè comments on the positive data from Istat in a note. Therefore, the credit for the recovery also goes to the pharmaceutical industry “despite the numerous cuts in the sector. After 'flying' in 2005 (+15%), the sector in fact consolidates its growth on international markets with an increase in the value of exports of 5% and a long-term growth higher than that of the industry (since 2001 +32% cumulative, compared to the industry's +19%)," he says.
Farmindustria emphasizes that “pharmaceutical companies are confirmed as an important driver of the country's knowledge economy and development. In 2006, the value of exports from the pharmaceutical industry (11.8 billion euros) was approximately equal to the total agreed pharmaceutical expenditure (12.3 billion, in public prices) and was higher than the industry revenue value of expenditure on medicines class A, paid by the National Health Service (8.5 billion, source Ims). This consolidates – continues Dompè – a result that has been recorded for over a decade now. The foreign balance of medicines is positive (1,285 million euros in 2006). The country produces more drugs than it consumes, demonstrating that it is not a mere commercial outlet market for foreign products".
Farmindustria emphasizes that “pharmaceutical companies are confirmed as an important driver of the country's knowledge economy and development. In 2006, the value of exports from the pharmaceutical industry (11.8 billion euros) was approximately equal to the total agreed pharmaceutical expenditure (12.3 billion, in public prices) and was higher than the industry revenue value of expenditure on medicines class A, paid by the National Health Service (8.5 billion, source Ims). This consolidates – continues Dompè – a result that has been recorded for over a decade now. The foreign balance of medicines is positive (1,285 million euros in 2006). The country produces more drugs than it consumes, demonstrating that it is not a mere commercial outlet market for foreign products".
“Italy – insists the president of Farmindustria – remains an important market, but also one of the most important producers on the international scene, the third in Europe according to Eurostat. Ultimately, the data show that drug companies should no longer be considered as a cost, but also as an investment". In this regard, the association of pharmaceutical manufacturers states that it does not seek “neither discounts nor assistance, but only wants to confirm itself as a forge of production, exports and innovation for the Italian system. And he calls for a new drug policy that recognizes its contribution to the country's economic growth".
From “pharmacist33”
From “pharmacist33”
